NL300121I1 - Nieuwe bacterie die een pluimveeziekte veroorzaakten een daarvan afgeleid vaccin. - Google Patents

Nieuwe bacterie die een pluimveeziekte veroorzaakten een daarvan afgeleid vaccin.

Info

Publication number
NL300121I1
NL300121I1 NL300121C NL300121C NL300121I1 NL 300121 I1 NL300121 I1 NL 300121I1 NL 300121 C NL300121 C NL 300121C NL 300121 C NL300121 C NL 300121C NL 300121 I1 NL300121 I1 NL 300121I1
Authority
NL
Netherlands
Prior art keywords
pct
caused
vaccine derived
poultry disease
disease
Prior art date
Application number
NL300121C
Other languages
English (en)
Other versions
NL300121I2 (nl
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8210967&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300121(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NL300121I1 publication Critical patent/NL300121I1/nl
Publication of NL300121I2 publication Critical patent/NL300121I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/82—Subcellular parts of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL300121C 1992-10-14 2003-03-27 Nieuwe bacterie die een pluimveeziekte veroorzaakten een daarvan afgeleid vaccin. NL300121I2 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP92203154 1992-10-14
EP93922957A EP0625190B1 (en) 1992-10-14 1993-10-14 New bacterium causing poultry disease and vaccine derived thereof
PCT/EP1993/002873 WO1994009114A1 (en) 1992-10-14 1993-10-14 New bacterium causing poultry disease and vaccine derived thereof

Publications (2)

Publication Number Publication Date
NL300121I1 true NL300121I1 (nl) 2003-06-02
NL300121I2 NL300121I2 (nl) 2003-07-01

Family

ID=8210967

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300121C NL300121I2 (nl) 1992-10-14 2003-03-27 Nieuwe bacterie die een pluimveeziekte veroorzaakten een daarvan afgeleid vaccin.

Country Status (12)

Country Link
US (3) US5576003A (nl)
EP (1) EP0625190B1 (nl)
JP (1) JP3992727B2 (nl)
AT (1) ATE146818T1 (nl)
DE (2) DE10399019I2 (nl)
DK (1) DK0625190T3 (nl)
ES (1) ES2098788T3 (nl)
GR (1) GR3022756T3 (nl)
HU (1) HU219311B (nl)
NL (1) NL300121I2 (nl)
WO (1) WO1994009114A1 (nl)
ZA (1) ZA937652B (nl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6483009B1 (en) 1997-02-21 2002-11-19 Danisco A/S Antisense intron inhibition of starch branching enzyme expression
EP1076567A4 (en) * 1998-05-15 2001-12-12 Mkb Invest Ltd Partnership COMPOSITION AND METHOD FOR IMMUNIZATION OF POULTRY
US6517844B1 (en) * 1999-05-14 2003-02-11 Marshall K. Brinton Compositions and method for immunizing polutry
AU2002213077A1 (en) * 2000-10-09 2002-04-22 Regents Of The University Of Minnesota Bird diagnostics and treatments
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
US7521060B2 (en) * 2001-10-26 2009-04-21 Boehringer Ingelheim Vetmedica S.A. De C.V. Pathogen for bacterial poultry disease
US20030149255A1 (en) * 2002-05-28 2003-08-07 Vanessa Lopes Bird diagnostics and treatments
DE602004019971D1 (de) * 2003-12-23 2009-04-23 Intervet Int Bv Kombinationsvakzine für geflügel
US20080008718A1 (en) * 2004-02-11 2008-01-10 Intervet International B.V. Ornithobacterium Rhinotracheale Subunit Vaccines
CN107550863B (zh) * 2017-09-20 2020-07-14 何诚 一种禽鼻气管鸟疫杆菌a/b血清型二价灭活疫苗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1036621A (en) * 1962-02-23 1966-07-20 Canadian Patents Dev Improvements in or relating to bacterial vaccines
US3534136A (en) * 1969-09-19 1970-10-13 Research Corp M.g. inoculum for poultry
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US4379140A (en) * 1981-01-12 1983-04-05 Brigham Young University Turkey rhinotracheitis vaccine
IL99097A0 (en) * 1990-09-05 1992-07-15 Akzo Nv Haemophilus paragallinarum vaccine

Also Published As

Publication number Publication date
EP0625190A1 (en) 1994-11-23
JP3992727B2 (ja) 2007-10-17
ZA937652B (en) 1994-05-04
US5576003A (en) 1996-11-19
ATE146818T1 (de) 1997-01-15
HU9401400D0 (en) 1994-08-29
WO1994009114A1 (en) 1994-04-28
DE69306934D1 (de) 1997-02-06
US5925361A (en) 1999-07-20
ES2098788T3 (es) 1997-05-01
US6114131A (en) 2000-09-05
DE10399019I2 (de) 2005-07-21
HU219311B (en) 2001-03-28
DE69306934T2 (de) 1997-05-28
EP0625190B1 (en) 1996-12-27
DK0625190T3 (da) 1997-06-16
JPH07502174A (ja) 1995-03-09
NL300121I2 (nl) 2003-07-01
DE10399019I1 (de) 2003-09-18
GR3022756T3 (en) 1997-06-30
HUT69794A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
DE69213010T2 (de) Verwendung eines Bakteriozin antibiotischen Agenten zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden.
TR200001835T2 (tr) Aşı.
ATE250937T1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
FI970799A (fi) Mutanttientoroksiini, joka on tehokas ei-toksinen oraalinen adjuvantti
DE69529748D1 (de) Polynukleotide vakzine gegen den papilloma virus
HK1045941B (zh) 過敏反應的治療
FI960977A0 (fi) Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet
AU7814498A (en) Multivalent (in ovo) avian vaccine
NL300183I1 (nl) Acellulair vaccin.
CA2134835A1 (en) Live in ovo vaccine
HUP0500238A2 (hu) Interleukin-12 alkalmazása állatgyógyászati vakcina adjuvánsként
NL300121I1 (nl) Nieuwe bacterie die een pluimveeziekte veroorzaakten een daarvan afgeleid vaccin.
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
CA2022420A1 (en) Escherichia coli vaccine
SE9003198D0 (sv) Fish vaccine comprising a virulent, invasive bacterium
HUP0301634A2 (hu) Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera
PL344851A1 (en) Bacterium of salmonella type and vaccine containing that bacterium for protecting animals against salmonellosis and method of obtaining such vaccine
BR9606725A (pt) Vacina para administração via mucosa eficaz para a proteção de frangos contra a queda de desempenho uso de um agente vivo atenuado de anemia de frango e processo para proteção de frangos contra a queda de desempenho
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
BR0007966A (pt) Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana
HUP0003845A2 (hu) Antimikrobiális 8a-azalidok alkalmazása